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ABSTRACT
Objectives: To evaluate the incidence of endometriosis among endometritis patients and its association with confound-
ing comorbidities. 
Material and methods: A population-based, retrospective cohort study of women aged between 20 to 55 years, who were 
newly diagnosed with endometritis between 2000 to 2013. A total of 16,830 endometritis patients and 67,230 non-en-
dometritis individuals were enrolled by accessing data from the National Health Insurance Research Database of Taiwan. 
The comorbidities accessed were uterine leiomyoma, rheumatoid arthritis, ovarian cancer, infertility and allergic diseases. 
Results: The mean follow-up period was 9.15 years for the non-endometritis cohort and 9.13 years for the endometritis 
cohort. There were significantly higher percentages of uterine leiomyoma, rheumatoid arthritis, infertility, ovarian cancer 
and allergic diseases in the endometritis cohort than in the non-endometritis cohort. Patients with endometritis had  
a 1.5-fold increased risk of their condition advancing to endometriosis (HR 1.58, 95% CI 1.48–1.68). 
Conclusions: Our results suggest that patients with endometritis exhibited a positive correlation in developing endome-
triosis.
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INTRODUCTION
Endometriosis is defined by the presence of endometrial 
epithelial and stromal tissue outside the uterine cavity. It is 
not considered a malignant disease, but it can lead to com-
mon symptoms such as dysmenorrhea, dyspareunia, pelvic 
pain, and reduced fertility. About 10% of all menstruating 
women have endometriosis [1, 2].
The processes associated with the pathogenesis of en-
dometriosis remain undetermined. Currently, the most 
agreed upon hypothesis is that of retrograde menstruation, 
through which endometrial tissues flow back through the fal-
lopian tubes into the peritoneal cavity, where they attach and 
develop to form pelvic endometriosis [3]. It should be noted 
that about 90% of women exhibit retrograde menstruation; 
however, in only 6–10% of them is endometriosis established 
[1, 4]. Therefore, retrograde menstruation can only be consid-
ered as a risk factor, and not an exact pathogenic factor. Varia-
tions in the genetic, biochemical, and physiological properties 
of the ovaries, rectovaginal septum, and peritoneum mean that 
endometriosis may result from diverse circumstances. 
Endometritis is characterized as a microbial infectious 
and inflammatory disease. Bacteria commonly detected 
in patients with endometritis include streptococcus spe-
cies, Escherichia coli, Enterococcus faecalis, staphylococcus 
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species, Mycoplasma genitalium, Mycoplasma hominis, 
Ureaplasma urealyticum, proteus species, Klebsiella pneu-
moniae, Pseudomonas aeruginosa, Gardnerella vaginalis, 
and Corynebacterium [5]. Yeasts such as Saccharomyces 
cerevisiae and candida species are also present in the endo-
metrium of patients with endometritis [5, 6]. Changes in the 
distribution of lactobacilli species in the female reproductive 
tract may represent another risk factor for endometritis [7, 8]. 
Objectives
The aim of this study was to explore the possible as-
sociation between endometritis and endometriosis. We 
analyzed data from the National Health Insurance Research 
Database (NHRID) of Taiwan through a retrospective cohort 
study to demonstrate whether patients with endometritis 
have a higher risk of endometriosis. 
MATERIAL AND METHODS 
Data source
We used the Longitudinal Health Insurance Database 
2000 which randomly selected one million participants from 
the NHIRD of Taiwan and made sure that the age and sex 
distributions were comparable to those of the Taiwanese 
population. The identity of each participant was protected by 
encrypting the identification number before the data were 
released. All history diagnoses in the database were coded 
according to the International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM). The Research Eth-
ics Committee of China Medical University and Hospital in 
Taiwan approved the study (CMUH-104-REC2-115-R3).
Study population
We enrolled 18,583 female patients who were aged be-
tween 20 and 55 years and newly diagnosed as having endo-
metritis (ICD-9-CM 615) from 2000 to 2012; the diagnosis date 
was defined as the index date. The non-endometritis cohort 
was matched 1:4 by age (in 5-year bands) and index year. 
We excluded patients with a pre-existing diagnosis of endo-
metriosis (ICD-9-CM 615.0–615.9) and those who could not 
match 4 controls. The same exclusion criteria were used in the 
non-endometritis cohort as in the endometritis cohort. A total 
of 16,830 endometritis patients and 67,320 non-endometritis 
patients were followed up to development of endometriosis, 
death, or until the end of the study (2013/12/31), whichever 
came first. We collected both demographic characteristics 
and endometriosis comorbidity history as potential con-
founders. The comorbidities included uterine leiomyoma 
(ICD-9-CM 218), rheumatoid arthritis (ICD-9-CM 714.0), ovar-
ian cancer (ICD-9-CM 183.0), multiple sclerosis (ICD-9-CM 
340), infertility (ICD-9-CM 628), cervical cancer (ICD-9-CM 
180), breast cancer (ICD-9-CM 174), autoimmune diseases 
(ICD-9-CM 710.0), and allergic diseases (ICD-9-CM 477) (Fig. 1).
Statistical analysis
Distribution of age, sex, and comorbidities between the 
endometritis cohort and non-endometritis cohort were de-
scribed in terms of numbers and percentages and tested using 
the Chi-square test and T test. The hazard ratio (HR) and 95% 
confidence interval (95% CI) were estimated using the Cox 
proportional hazard model for evaluating the association 
between endometritis and endometriosis. The multivariate 
Cox proportional hazard model was used to estimate the HRs 
after adjustment for age, gender, and comorbidities, which 
were notably different in the univariate model or with/without 
comorbidity. Analysis of stratification by age and comorbidity 
was performed to explore the association between endometri-
Participants in LHID 
2000 database (1996–2013)
(n = 1,000,000)
Include
Patients with at least 
two outpatient visits or 
one inpatient care with 
endometritis diagnosis 
(ICD-9:615)
Patients with endometritis 
(1996–2013)
(n = 23,837)
Exclusion Criteria
1. Endometritis date out 
of the study period 
(2000–2012) (n = 2840)
2. Male (n = 4)
3. Age < 20 or 
age ≥ 55 (n = 2,410)
Patients in 2000 to 
2012 newly diagnosed as 
endometritis (n = 18,583)
Using the same exclusion 
criteria as case cohort 
and 1:4 frequency mat-
ched by 5-year age and 
diagnosis year
16,830 endometritis patients and 67,320 non-endome-
tritis patients followed up to endometriosis or until the 
end of the study (2013/12/31)
1. Excluded patients with a preexist-
ing diagnosis or on the same day 
of endometriosis (n = 904)
2. Excluded patients who can not 
match 4 controls (n = 849)
Figure 1. Subject selection process
195
Kent Yu-Hsien Lin et al., Increased risk of endometriosis in patients with endometritis — a nationwide cohort study involving 84,150 individuals
www. journals.viamedica.pl/ginekologia_polska
tis and endometriosis among specific populations. Cumulative 
incidence curves for endometriosis were computed using the 
Kaplan–Meier method, and differences between the endo-
metritis cohort and the non-endometritis cohort were tested 
using a log-rank test. All statistical analyses were performed 
using Stata Statistical Software version 14 (StataCorp, College 
Station, TX, USA). Statistical significance was determined using 
two‐tailed tests (p < 0.05).
RESULTS
The mean ages were 34.2 years and 34.1 years in the 
non-endometritis cohort and endometritis cohort, re-
spectively. There were significantly higher percentages of 
uterine leiomyoma, rheumatoid arthritis, infertility, and 
allergic diseases in the endometritis cohort than in the 
non-endometritis cohort. The endometritis cohort also had 
a considerably lower percentage of ovarian cancer patients 
than the non-endometritis cohort (Tab. 1). 
The mean follow-up period was 9.15 years for the 
non-endometritis cohort and 9.13 years for the endome-
tritis cohort (p = 0.479). Associations of endometritis and 
other risk factors with endometriosis are shown in Table 2. 
Compared to non-endometritis patients, patients with en-
dometritis had a 1.58-fold adjusted HR of development of 
endometriosis after adjustment for age and with/without 
comorbidity (model 1). Compared to patients aged 20– 
–25 years, there were a 1.38-, 1.58-, 1.91-, and 1.59-fold risks 
of development of endometriosis in patients aged 25–30, 
30–35, 35–40, and 40–45 years, respectively. However, pa-
tients aged 45–50 and 50–55 years had a significantly lower 
risk, with adjusted HRs of 0.79 and 0.14, respectively. 
Compared to patients without comorbidity, patients 
with any one of the comorbidities had a 1.59-fold risk of 
developing endometriosis. After adjustment for age and 
the comorbidities of uterine leiomyoma, rheumatoid ar-
thritis, infertility, and allergic diseases (model 2), patients 
with endometritis had a notably higher risk of endometrio-
sis than non-endometritis patients [adjusted HR (95% CI) 
1.55 (1.45–1.65)]. The association between age and endome-
triosis in model 2 was similar to that in model 1. Compared to 
Table 1. Baseline characteristics of patients
Endometritis
p-value*
No Yes
(n = 67,320) (n = 16,830)
n % n %
Age > 0.99
20–25 12736 18.92 3184 18.92
25–30 13392 19.89 3348 19.89
30–35 11728 17.42 2932 17.42
35–40 10448 15.52 2612 15.52
40–45 9028 13.41 2257 13.41
45–50 6532 9.7 1633 9.7
50–55 3456 5.13 864 5.13
Mean (SD) 34.2 (9.1) 34.1 (9.0) 0.467a
Childbirth < 0.001
No 51747 76.87 11289 67.08
Yes 15573 23.13 5541 32.92
Comorbidity
Uterine leiomyoma 2544 3.78 1104 6.56 < 0.001
Rheumatoid arthritis 416 0.62 140 0.83 0.002
Ovarian cancer 40 0.06 2 0.01 0.014
Multiple sclerosis 20 0.03 7 0.04 0.441
Infertility 1539 2.29 698 4.15 < 0.001
Cervical cancer 130 0.19 33 0.2 0.938
Breast cancer 202 0.3 52 0.31 0.85
Autoimmune 263 0.39 72 0.43 0.494
Allergic disease 10138 15.06 2978 17.69 < 0.001
*Chi-square test; at-test
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patients without rheumatoid arthritis, infertility and allergic 
diseases, patients with these diseases exhibited positive as-
sociation with the development of endometriosis.
Analysis of stratification by age and comorbidity are 
shown in Table 3. Except for patients older than 50 years, 
there were significantly higher risks of endometriosis in pa-
tients with endometritis than in non-endometritis patients 
in every age stratification (adjusted HR 1.33–2.16). Among 
patients without any one of the comorbidities, patients with 
endometritis had a 1.55-fold risk of endometriosis compared 
to non-endometritis patients. Among patients with any one 
of the comorbidities, patients with endometritis had a 1.64-
-fold risk of endometriosis compared to non-endometritis 
patients. Endometritis was significantly associated with 
endometriosis among patients with uterine leiomyoma 
[adjusted HR (95% CI) 1.63 (1.34–1.98)], infertility [adjusted 
Table 2. Incidence and hazard ratio of endometriosis for endometritis patients compared to controls
Crude
Model 1a
Adjusted
Model 2b
Event PY IR HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Endometritis
No 3345 615940 5.43 Reference Reference Reference
Yes 1348 153604 8.78 1.62 (1.52–1.72) < 0.001 1.60 (1.50–1.70) < 0.001 1.57 (1.47–1.67) < 0.001
Age
20–25 663 146805 4.52 Reference Reference Reference
25–30 938 147361 6.37 1.41 (1.27–1.55) < 0.001 1.42 (1.29–1.57) < 0.001 1.41 (1.28–1.56) < 0.001
30–35 960 132994 7.22 1.60 (1.45–1.77) < 0.001 1.65 (1.49–1.83) < 0.001 1.60 (1.45–1.78) < 0.001
35–40 1056 120746 8.75 1.94 (1.76–2.14) < 0.001 1.96 (1.78–2.16) < 0.001 1.85 (1.68–2.04) < 0.001
40–45 774 106683 7.26 1.61 (1.45–1.79) < 0.001 1.58 (1.43–1.75) < 0.001 1.43 (1.29–1.59) < 0.001
45–50 277 76673 3.61 0.80 (0.70–0.92) 0.002 0.77 (0.67–0.89) < 0.001 0.69 (0.60–0.80) < 0.001
50–55 25 38282 0.65 0.14 (0.10–0.22) < 0.001 0.14 (0.09–0.20) < 0.001 0.12 (0.08–0.18) < 0.001
Childbirth
No 3458 584540 5.92 Reference Reference Reference
Yes 1235 185003 6.68 1.12 (1.05–1.20) 0.001 0.87 (0.81–0.93) < 0.001 0.87 (0.81–0.93) < 0.001
Comorbidity
No 3444 630892 5.46 Reference Reference
Yesc 1249 138652 9.01 1.63 (1.52–1.73) < 0.001 1.60 (1.50–1.71) < 0.001
Uterine leiomyoma
No 4267 740818 5.76 Reference Reference
Yes 426 28726 14.83 2.55 (2.31–2.81) < 0.001 2.67 (2.40–2.96) < 0.001
Rheumatoid arthritis
No 4661 765068 6.09 Reference Reference
Yes 32 4476 7.15 1.16 (0.82–1.64) 0.403 1.13 (0.79–1.59) 0.507
Ovarian cancer
No 4692 769246 6.10 Reference Reference
Yes 1 298 3.36 0.54 (0.08–3.84) 0.539 0.43 (0.06–3.09) 0.405
Infertility
No 4500 752153 5.98 Reference Reference
Yes 193 17391 11.10 1.83 (1.59–2.11) < 0.001 1.44 (1.24–1.66) < 0.001
Allergic disease
No 3930 670894 5.86 Reference Reference
Yes 763 98650 7.73 1.30 (1.20–1.40) < 0.001 1.24 (1.15–1.35) < 0.001
Event: No. patients with endometriosis; PY — person-years; IR — incidence rate, per 1,000-person years; HR — hazard ratio; CI — confidence interval 
aAdjusted for age and with/without comorbidity 
bAdjusted for age, uterine leiomyoma, rheumatoid arthritis, ovarian cancer, infertility, and allergic disease 
cPatients with any one of the comorbidities were classified as the comorbidity group
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HR (95% CI) 1.58 (1.18–2.11)], and allergic diseases [adjusted 
HR (95% CI) 1.50 (1.29–1.75)].
During the whole follow-up period there was a sig-
nificantly higher cumulative incidence of endometriosis for 
patients with endometritis than patients without endome-
tritis (log-rank p < 0.0001) (Fig. 2). There was a considerably 
different cumulative incidence of endometriosis in the differ-
ent age stratifications (log-rank p < 0.0001) (Fig. 3). Patients 
with comorbidity had significantly higher cumulative inci-
dences of endometriosis than patients without comorbid-
ity (log-rank p < 0.0001) (Fig. 4). Among patients with any 
one of the comorbidities, patients with endometritis had 
Figure 2. Cumulative incidence curve of endometriosis between 
endometritis patients and non-endometritis patients
Table 3. Incidence and hazard ratio of endometriosis for endometritis 
patients compared to controls stratified by age, childbirth, and 
comorbidities
Crude Adjusted
HR (95% CI) p-value HR (95% CI)a p-value
Overall
Age
20–25 1.35  (1.13–1.60) 0.001
1.38  
(1.15–1.65) < 0.001
25–30 1.57  (1.36–1.81) < 0.001
1.57  
(1.36–1.81) < 0.001
30–35 1.58  (1.37–1.82) < 0.001
1.56  
(1.35–1.79) < 0.001
35–40 1.51  (1.32–1.73) < 0.001
1.44  
(1.26–1.66) < 0.001
40–45 1.87  (1.61–2.18) < 0.001
1.77  
(1.52–2.06) < 0.001
45–50 2.37  (1.86–3.03) < 0.001
2.16  
(1.69–2.76) < 0.001
50–55 1.88  (0.81–4.36) 0.14
1.77  
(0.76–4.12) 0.188
Childbirth
No 1.72  (1.59–1.85) < 0.001
1.64  
(1.52–1.77) a < 0.001
Yes 1.36  (1.21–1.54) < 0.001
1.42  
(1.26–1.60) a < 0.001
Uterine leiomyoma
No 1.55  (1.45–1.66) < 0.001
1.56  
(1.45–1.66) < 0.001
Yes 1.69  (1.39–2.04) < 0.001
1.63  
(1.34–1.98) < 0.001
Rheumatoid arthritis
No 1.62  (1.52–1.73) < 0.001
1.57  
(1.47–1.68) < 0.001
Yes 1.04  (0.47–2.32) 0.919
1.12  
(0.49–2.55) 0.783
Ovarian cancer
No 1.62  (1.52–1.72) < 0.001
1.57  
(1.47–1.67) < 0.001
Yes – – – –
Infertility
No 1.60  (1.50–1.71) < 0.001
1.56  
(1.46–1.67) < 0.001
Yes 1.62  (1.22–2.16) 0.001
1.56  
(1.17–2.08) 0.003
Allergic disease
No 1.62  (1.51–1.74) < 0.001
1.57  
(1.47–1.69) < 0.001
Yes 1.55  (1.33–1.81) < 0.001
1.55  
(1.33–1.81) < 0.001
HR — hazard ratio; CI — confidence interval; aAdjusted for other covariates
Figure 3. Cumulative incidence curve of endometriosis in each age 
group
Figure 4. Cumulative incidence curve of endometriosis in patients 
with comorbidity and without comorbidity
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particularly higher cumulative incidences of endometriosis 
than non-endometritis patients (log-rank p < 0.0001) (Fig. 5). 
Among patients without comorbidity, those with endome-
tritis also had considerably higher cumulative incidences of 
endometriosis than non-endometritis patients (log-rank 
p < 0.0001) (Fig. 6).
DISCUSSION
This nationwide retrospective cohort study revealed 
that patients with endometritis had a 1.5-fold increase in the 
risk of developing endometriosis, compared with women 
without endometritis. Uterine leiomyoma, infertility, rheu-
matoid arthritis, and allergic diseases exhibit higher inci-
dences in women with endometritis. It is not known why 
the frequency of ovarian cancer was lower in patients with 
endometritis. Although we found a significant association of 
endometritis with endometriosis, this association should be 
viewed with caution: the association between endometritis 
and the incidence of endometriosis may result from a causal 
connection, which may indicate that endometritis might 
incline women to the development of endometriosis. In 
addition, there might be a third confounding variable, which 
implies that there is an overlapping risk factor or pathologi-
cal process which alters the development of endometritis 
and endometriosis.
Local chronic inflammation has been suggested as a risk 
factor for the development of endometriosis [9–11]. In-
creasing levels of monocyte chemotactic protein 1 (MCP-1), 
interleukin (IL)-8, IL-6, IL-1β, and tumor necrosis factor 
(TNF)-α enhance the implantation of ectopic endometrial 
tissue [12–14]. In addition, the inflammatory cytokines and 
chemokines secreted by ectopic endometriotic tissues at-
tract macrophages to the peritoneal cavity, which enhances 
inflammation [15]. The number of activated macrophages 
in the peritoneal cavity of patients with endometriosis is 
elevated [16]. It is possible that inflammation in the peri-
toneal cavity may be related to infections [17], with in-
creased production of inflammatory cytokines through 
bacterial infection further enhancing the development of 
endometriosis [18]. The induction of inflammation may be 
related to infections in the upper reproductive tract, lower 
reproductive tract, or pelvis [17, 19, 20]. Bacterial coloniza-
tion increases the levels of inflammatory mediators, which 
promote development of endometriosis [18].
Imbalance and inflammatory reactions are two poten-
tial factors linked with endometritis and endometriosis. In 
Rhesus monkeys with endometriosis, the levels of intestinal 
microflora were changed, with these monkeys showing 
lower amounts of lactobacilli but higher concentrations of 
gram-negative bacteria [21]. It was found that the number 
of E. coli in the menstrual blood of patients with endome-
triosis was elevated. The endotoxin levels in menstrual and 
peritoneal fluid were also elevated [22]. Bacterial endotoxins 
could promote inflammation by inducing the expression of 
inflammatory cytokines and chemokines [23]. The inflamma-
tory cytokines and chemokines could attract macrophages, 
which can be activated by endotoxins through toll-like 
receptor 4 (TLR4). Activated macrophages would further 
sustain/amplify inflammatory reactions [23]. The bacteria 
present in the uterine cavity and peritoneal fluid might 
induce the TLR4-mediated growth of endometrial lesions 
[24]. In cystic fluid of patients with ovarian endometriosis, 
presence of the Streptococcaceae and Staphylococcaceae 
families is significantly elevated [25]. The imbalance of endo-
metrial microbiota in the uterine cavity could influence the 
balance of immune responses which increase inflammation, 
thus promoting the pathogenesis of endometriosis [26]. 
The varied concentrations of estradiol and progesterone 
during the menstrual cycle have significant consequences 
for the balance of the microbiota, which may promote infec-
tions. Estradiol encourages the infiltration of macrophages 
into the endometrium to reduce the risk of bacterial infec-
tions [27, 28]. A high concentration of progesterone reduces 
uterus lymphocyte infiltration, which may increase the risk 
Figure 5. Cumulative incidence curve of endometriosis between 
patients with endometritis and non-endometritis, among patients 
without any of the comorbidities listed in Table 2
Figure 6. Cumulative incidence curve of endometriosis between 
patients with endometritis and non-endometritis, among patients 
with any one of the comorbidities listed in Table 2
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of bacterial infections [27, 28]. The growth of eutopic and 
ectopic endometriotic tissues could be enhanced by treat-
ment with bacterial endotoxins. In endometrial stromal 
cells and macrophages treated with bacterial endotoxins, 
levels of hepatocyte growth factor, vascular endothelial cell 
growth factor (VEGF), IL-6, IL-8, and TNF-α were elevated 
[29, 30]. The expression of VEGF is important to sustain the 
growth of eutopic and ectopic endometriotic tissues [31, 32]. 
Treating endometrial stromal cells with combined estradiol 
and lipopolysaccharide significantly increased the prolifera-
tion rate [33]. Moreover, the expression levels of IL-6 and 
TNF-α were higher in macrophages isolated from patients 
with endometriosis [34]. These findings suggest that estra-
diol and progesterone levels influence the risk of bacterial 
infection in the female reproductive tract and promote the 
expansion of ectopic and eutopic endometriotic tissues to 
encourage endometriosis. 
There are various limitations of this study. First, this is 
a retrospective cohort study, which makes it hard to define 
the causation of the two associated diseases. Secondly, we 
used insurance claims data to select our study population 
by ICD coding, which could have resulted in misclassification 
bias. Thirdly, we could not ascertain reasons why partici-
pants were lost to follow-up. It should also be noted that 
patients with endometritis would probably have a higher 
chance of being diagnosed with endometriosis since they 
may receive more medical attention to the female repro-
ductive tract than those without the disease. In addition to 
age and the comorbidities that were adjusted for, there are 
still some confounding variables. Body mass index (BMI), 
number of births, use of birth control pills or devices, and 
length and interval of menstrual cycle were not analyzed in 
this study. A more detailed prospective cohort study should 
be conducted to understand the correlation between en-
dometritis and endometriosis better. 
In conclusion, the results of this study indicate that pa-
tients with endometritis are at higher risk of developing 
endometriosis compared with patients without endome-
tritis. This indicates that either endometritis predisposes 
to endometriosis or that some specific pathogenic factors 
influence the development of both conditions. Although 
the exact pathological factors are not yet known, these 
findings make a meaningful contribution to the diagnosis 
and management of patients with endometritis. 
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